Safety and Efficacy of BFH772 in Psoriasis Patients
NCT00987870 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2011-03-28
Summary
This study will determine the efficacy of topical BFH772 in psoriasis patients and the safety after multiple dosing.
Conditions
Interventions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2010-02-28
Countries
- Germany
Study Locations
More Related Trials
-
Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis
NCT02548052 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis
NCT02274792 ·Status: COMPLETED ·Phase: PHASE4
-
Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
NCT01230138 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
NCT03895372 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis
NCT03469336 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00678210 ·Status: COMPLETED ·Phase: PHASE2
-
A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
NCT01309737 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
NCT01871402 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of CF101 to Treat Psoriasis
NCT00428974 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Management of Patients With Moderate and Severe Psoriasis
NCT00894777 ·Status: COMPLETED
-
A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis
NCT01610596 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment of Plaque-Type Psoriasis
NCT00373516 ·Status: COMPLETED ·Phase: PHASE2
-
Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis
NCT00692172 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
NCT01241591 ·Status: COMPLETED ·Phase: PHASE3
-
Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques
NCT05642182 ·Status: RECRUITING ·Phase: PHASE1
-
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
NCT03210961 ·Status: COMPLETED ·Phase: PHASE1
-
A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis
NCT01276639 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis
NCT03850483 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis
NCT00759161 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
NCT02564042 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis
NCT02785172 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis
NCT03004846 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis
NCT00747032 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis
NCT04594928 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test
NCT04221906 ·Status: COMPLETED ·Phase: PHASE1